Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jun 18 |
| AVIR |
| Atea Pharmaceuticals, Inc. |
| MEXER◆ |
| 29,600 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 18 | AVIR | Atea Pharmaceuticals, Inc. | MEXER | 29,600 | — | — | +5.8% | Open the original filing on SEC.gov |
| May 11 | KZR | Kezar Life Sciences, Inc. | DTOISS◆ | 2,600 | — | — | — | Open the original filing on SEC.gov |
| May 11 | KZR | Kezar Life Sciences, Inc. | DTOISS◆ | 2,600 | — | — | — | Open the original filing on SEC.gov |
| May 11 | KZR | Kezar Life Sciences, Inc. | DTOISS◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| May 11 | KZR | Kezar Life Sciences, Inc. | DTOISS◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| May 11 | KZR | Kezar Life Sciences, Inc. | DTOISS◆ | 3,500 | — | — | — | Open the original filing on SEC.gov |
| May 11 | KZR | Kezar Life Sciences, Inc. | UTENDR | 89,069 | — | — | -100.0% | Open the original filing on SEC.gov |